Bhaskar Anand, SVP, Chief Accounting Officer at REATA PHARMACEUTICALS INC (RETA), sold 165 shares at $84.58 ($14K) on 2023-03-07, disclosed to the SEC on 2023-03-08.
Open-market sale of $14k RETA by SVP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RETA | SELL | 2023-06-16 | $478K | — | Filing → |
| RETA | SELL | 2023-05-17 | $93K | — | Filing → |
| RETA | SELL | 2023-03-06 | $143K | — | Filing → |